# Lineage Cell Therapeutics, Inc.: Form SC 13D/A, filed Feb 8, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: SC 13D/A
- Filed: 2024-02-08
- Accepted by EDGAR: Feb 8, 2024, 18:57 ET
- Period: not reported
- Accession: 0000919574-24-000756
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000091957424000756/d10974070_13d-a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000091957424000756/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000091957424000756/d10974070_13d-a.htm

Filed Feb 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000919574-24-000756. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.